Cargando…
The N‐glycan profile in cortex and hippocampus is altered in Alzheimer disease
Protein glycosylation is crucial for the central nervous system and brain functions, including processes that are defective in Alzheimer disease (AD) such as neurogenesis, synaptic function, and memory formation. Still, the roles of glycans in the development of AD are relatively unexplored. Glycomi...
Autores principales: | Gaunitz, Stefan, Tjernberg, Lars O., Schedin‐Weiss, Sophia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596851/ https://www.ncbi.nlm.nih.gov/pubmed/32986846 http://dx.doi.org/10.1111/jnc.15202 |
Ejemplares similares
-
What Can N-glycomics and N-glycoproteomics of Cerebrospinal Fluid Tell Us about Alzheimer Disease?
por: Gaunitz, Stefan, et al.
Publicado: (2021) -
Glycan biomarkers for Alzheimer disease correlate with T‐tau and P‐tau in cerebrospinal fluid in subjective cognitive impairment
por: Schedin‐Weiss, Sophia, et al.
Publicado: (2020) -
A Super-Resolved View of the Alzheimer’s Disease-Related Amyloidogenic Pathway in Hippocampal Neurons
por: Yu, Yang, et al.
Publicado: (2021) -
Microdissected Pyramidal Cell Proteomics of Alzheimer Brain Reveals Alterations in Creatine Kinase B-Type, 14-3-3-γ, and Heat Shock Cognate 71
por: Sandebring-Matton, Anna, et al.
Publicado: (2021) -
Neuronal Trafficking of the Amyloid Precursor Protein—What Do We Really Know?
por: Lin, Tong, et al.
Publicado: (2021)